JENNIFER FOWLER: Open Payments
NPI 1770916884 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 37 payments from 11 companies in 2025. Trend: 2023 $235 · 2024 $417 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $169 |
| ABBVIE INC. | 19 | $158 |
| Lilly USA, LLC | 3 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $18 |
Products named: TREMFYA, OMVOH, XIFAXAN, RINVOQ, SKYRIZI, REZDIFFRA, DUPIXENT, MAVYRET.
Industry payments across KS — which companies pay providers there.
